TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharem Biotech AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,257
|
1,123
|
375 |
Financial expenses |
351
|
156
|
20 |
Earnings before taxes |
-3,085
|
-5,139
|
-4,590 |
EBITDA |
707
|
-1,462
|
-699 |
Total assets |
11,355
|
14,911
|
25,288 |
Current assets |
4,547
|
4,714
|
10,362 |
Current liabilities |
6,649
|
5,820
|
7,013 |
Equity capital |
4,706
|
5,691
|
11,785 |
- share capital |
72
|
69
|
76 |
Employees (average) |
5
![]() |
5
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
41.4%
|
38.2%
|
46.6% |
Turnover per employee |
451
|
225
|
125 |
Profit as a percentage of turnover |
-136.7%
|
-457.6%
|
-1224.0% |
Return on assets (ROA) |
-24.1%
|
-33.4%
|
-18.1% |
Current ratio |
68.4%
|
81.0%
|
147.8% |
Return on equity (ROE) |
-65.6%
|
-90.3%
|
-38.9% |
Change turnover |
1,129
|
778
|
-265 |
Change turnover % |
100%
|
226%
|
-41% |
Chg. No. of employees |
0
|
2
|
-2 |
Chg. No. of employees % |
0%
|
67%
|
-40% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.